Current influenza vaccination strategies primarily elicit antibodies that bind to influenza hemagglutinin (HA) and neuraminidase (NA) glycoproteins on the surface of the virus and block viral infection and spread from cell to cell [1, 2]. The gene discussed is XK; the disease is influenza.